Sexual pain among malaysian women receiving antidepressant: A comparison between escitalopram and fluoxetine

Hatta Sidi, Duni Asmidar, Loh Huai Seng, Nik Ruzyanei Nik Jaafar, Marhani Midi, Ng Chong Guan

Research output: Contribution to journalArticle

Abstract

Objective: The current study compares the risk of sexual pain in depressed female patients in remission between those who were treated with Escitalopram and Fluoxetine. The associated factors were also examined. Methods: This is a cross-sectional study involved 112 depressed female patients (56 treated with Escitalopram and 56 treated with Fluoxetine) who were in remission (as defined by Diagnostic and Statistical Manual-IV (DSM-IV) in the past 2 months and Montgomery-Asberg Depression Rating Scale (MADRS) score of ≤ 10) from the psychiatric clinic, University Kebangsaan Malaysia Medical Centre (UKMMC). They were interviewed using Structured Clinical Interview for DSM-IV (SCID). Hypoactive sexual desire was assessed using the Pain subscale of Malay Version of the Female Sexual Function Index (MVFSFI). Results: The results show that risk of sexual pain was relatively low (16.07% for all patients), with no statistical significant between the two groups (17.86% for fluoxetine group, 14.29% for escitalopram group). Older age (adjusted odds ratio = 1.524, 95% CI = 1.199, 1.938) was the only factor significantly associated with sexual pain disorder. Conclusions: There should not be any barrier when continuing the use of escitalopram or fluoxetine as antidepressants amongst the female patients.

Original languageEnglish
Pages (from-to)24-35
Number of pages12
JournalPsychopharmacology Bulletin
Volume46
Issue number1
Publication statusPublished - 2016

Fingerprint

Citalopram
Fluoxetine
Antidepressive Agents
Pain
Somatoform Disorders
Malaysia
Psychiatry
Cross-Sectional Studies
Odds Ratio
Interviews
Depression

Keywords

  • Depression
  • Escitalopram
  • Female
  • Fluoxetine
  • Sexual pain

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Sexual pain among malaysian women receiving antidepressant : A comparison between escitalopram and fluoxetine. / Sidi, Hatta; Asmidar, Duni; Seng, Loh Huai; Nik Jaafar, Nik Ruzyanei; Midi, Marhani; Guan, Ng Chong.

In: Psychopharmacology Bulletin, Vol. 46, No. 1, 2016, p. 24-35.

Research output: Contribution to journalArticle

@article{ab0b4eb5868b4caaa3b712f88cfe705c,
title = "Sexual pain among malaysian women receiving antidepressant: A comparison between escitalopram and fluoxetine",
abstract = "Objective: The current study compares the risk of sexual pain in depressed female patients in remission between those who were treated with Escitalopram and Fluoxetine. The associated factors were also examined. Methods: This is a cross-sectional study involved 112 depressed female patients (56 treated with Escitalopram and 56 treated with Fluoxetine) who were in remission (as defined by Diagnostic and Statistical Manual-IV (DSM-IV) in the past 2 months and Montgomery-Asberg Depression Rating Scale (MADRS) score of ≤ 10) from the psychiatric clinic, University Kebangsaan Malaysia Medical Centre (UKMMC). They were interviewed using Structured Clinical Interview for DSM-IV (SCID). Hypoactive sexual desire was assessed using the Pain subscale of Malay Version of the Female Sexual Function Index (MVFSFI). Results: The results show that risk of sexual pain was relatively low (16.07{\%} for all patients), with no statistical significant between the two groups (17.86{\%} for fluoxetine group, 14.29{\%} for escitalopram group). Older age (adjusted odds ratio = 1.524, 95{\%} CI = 1.199, 1.938) was the only factor significantly associated with sexual pain disorder. Conclusions: There should not be any barrier when continuing the use of escitalopram or fluoxetine as antidepressants amongst the female patients.",
keywords = "Depression, Escitalopram, Female, Fluoxetine, Sexual pain",
author = "Hatta Sidi and Duni Asmidar and Seng, {Loh Huai} and {Nik Jaafar}, {Nik Ruzyanei} and Marhani Midi and Guan, {Ng Chong}",
year = "2016",
language = "English",
volume = "46",
pages = "24--35",
journal = "Psychopharmacology Bulletin",
issn = "0048-5764",
publisher = "MedWorks Media LLC",
number = "1",

}

TY - JOUR

T1 - Sexual pain among malaysian women receiving antidepressant

T2 - A comparison between escitalopram and fluoxetine

AU - Sidi, Hatta

AU - Asmidar, Duni

AU - Seng, Loh Huai

AU - Nik Jaafar, Nik Ruzyanei

AU - Midi, Marhani

AU - Guan, Ng Chong

PY - 2016

Y1 - 2016

N2 - Objective: The current study compares the risk of sexual pain in depressed female patients in remission between those who were treated with Escitalopram and Fluoxetine. The associated factors were also examined. Methods: This is a cross-sectional study involved 112 depressed female patients (56 treated with Escitalopram and 56 treated with Fluoxetine) who were in remission (as defined by Diagnostic and Statistical Manual-IV (DSM-IV) in the past 2 months and Montgomery-Asberg Depression Rating Scale (MADRS) score of ≤ 10) from the psychiatric clinic, University Kebangsaan Malaysia Medical Centre (UKMMC). They were interviewed using Structured Clinical Interview for DSM-IV (SCID). Hypoactive sexual desire was assessed using the Pain subscale of Malay Version of the Female Sexual Function Index (MVFSFI). Results: The results show that risk of sexual pain was relatively low (16.07% for all patients), with no statistical significant between the two groups (17.86% for fluoxetine group, 14.29% for escitalopram group). Older age (adjusted odds ratio = 1.524, 95% CI = 1.199, 1.938) was the only factor significantly associated with sexual pain disorder. Conclusions: There should not be any barrier when continuing the use of escitalopram or fluoxetine as antidepressants amongst the female patients.

AB - Objective: The current study compares the risk of sexual pain in depressed female patients in remission between those who were treated with Escitalopram and Fluoxetine. The associated factors were also examined. Methods: This is a cross-sectional study involved 112 depressed female patients (56 treated with Escitalopram and 56 treated with Fluoxetine) who were in remission (as defined by Diagnostic and Statistical Manual-IV (DSM-IV) in the past 2 months and Montgomery-Asberg Depression Rating Scale (MADRS) score of ≤ 10) from the psychiatric clinic, University Kebangsaan Malaysia Medical Centre (UKMMC). They were interviewed using Structured Clinical Interview for DSM-IV (SCID). Hypoactive sexual desire was assessed using the Pain subscale of Malay Version of the Female Sexual Function Index (MVFSFI). Results: The results show that risk of sexual pain was relatively low (16.07% for all patients), with no statistical significant between the two groups (17.86% for fluoxetine group, 14.29% for escitalopram group). Older age (adjusted odds ratio = 1.524, 95% CI = 1.199, 1.938) was the only factor significantly associated with sexual pain disorder. Conclusions: There should not be any barrier when continuing the use of escitalopram or fluoxetine as antidepressants amongst the female patients.

KW - Depression

KW - Escitalopram

KW - Female

KW - Fluoxetine

KW - Sexual pain

UR - http://www.scopus.com/inward/record.url?scp=85021312162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021312162&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85021312162

VL - 46

SP - 24

EP - 35

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

SN - 0048-5764

IS - 1

ER -